Walleye Capital LLC Crispr Therapeutics Ag Transaction History
Walleye Capital LLC
- $20.4 Billion
- Q1 2025
A detailed history of Walleye Capital LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Walleye Capital LLC holds 158,435 shares of CRSP stock, worth $6.03 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
158,435
Previous 38,000
316.93%
Holding current value
$6.03 Million
Previous $1.5 Million
260.6%
% of portfolio
0.03%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CRSP
# of Institutions
479Shares Held
64.2MCall Options Held
2.15MPut Options Held
1.92M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$387 Million3.73% of portfolio
-
Capital International Investors Los Angeles, CA6.07MShares$231 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.8MShares$144 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$106 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.54MShares$96.6 Million1.16% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $2.97B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....